Literature DB >> 22488601

Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management.

Robert de W Marsh1, Marc Alonzo, Shailesh Bajaj, Marshall Baker, Eric Elton, Thomas A Farrell, Richard M Gore, Curtis Hall, Jan Nowak, Hemant Roy, Arif Shaikh, Mark S Talamonti.   

Abstract

Biliary tract cancers (gallbladder cancer, intra- and extra-hepatic cholangiocarcinoma and selected periampullary cancers) accounted for 12,760 new cases of cancer in the USA in 2010. These tumors have a dismal prognosis with most patients presenting with advanced disease. Early, accurate diagnosis is essential, both for potential cure where possible and for optimal palliative therapy in all others. This review examines the currently available and emerging technologies for diagnosis and treatment of this group of diseases.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22488601     DOI： 10.1002/jso.23027

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  11 in total

Review 1.  Successful percutaneous endobiliary radiofrequency ablation for unresectable malignant biliary obstruction: a case report and review of the literature.

Authors:  Eric J Mao; James B Watson; Gregory Soares; Fadlallah G Habr
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 2.  Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.

Authors:  Jason K Sicklick; Paul T Fanta; Kelly Shimabukuro; Razelle Kurzrock
Journal:  Cancer Metastasis Rev       Date:  2016-06       Impact factor: 9.264

3.  Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.

Authors:  Jun Wang; Zhi Peng Gao; Song Qin; Chang Bai Liu; Li Li Zou
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

Review 4.  Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.

Authors:  Wen-Lung Ma; Hsueh-Chou Lai; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

5.  Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis.

Authors:  Gui-Jie Liu; Xue-Hua Li; Yan-Xin Chen; Hui-Dong Sun; Gui-Mei Zhao; San-Yuan Hu
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

6.  Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyungsung Kim; Seongsik Bang; Seungyun Jee; Seongun Park; Su-Jin Shin; Kiseok Jang
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

7.  The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.

Authors:  Yoshiyuki Yamamura; Takahiro Tsuchikawa; Kengo Miyauchi; Shintaro Takeuchi; Masataka Wada; Toshihiko Kuwatani; Noriaki Kyogoku; Aki Kuroda; Takehiro Maki; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Int J Clin Oncol       Date:  2014-06-28       Impact factor: 3.402

8.  FXYD6 is a new biomarker of cholangiocarcinoma.

Authors:  Xiongfei Chen; Mingzhu Sun; Yazhuo Hu; Honghong Zhang; Zhanbo Wang; Ningxin Zhou; Xinyun Yan
Journal:  Oncol Lett       Date:  2013-12-04       Impact factor: 2.967

9.  Impact of 18F-FDG-PET/CT on Clinical Management in Patients with Cholangiocellular Carcinoma.

Authors:  Lena Sophie Kiefer; Julia Sekler; Brigitte Gückel; Mareen Sarah Kraus; Christian la Fougère; Konstantin Nikolaou; Michael Bitzer; Sergios Gatidis; Christina Pfannenberg
Journal:  BJR Open       Date:  2021-07-05

Review 10.  Advances in systemic therapy for advanced pancreatobiliary malignancies.

Authors:  Thorvardur R Halfdanarson; Sigurdis Haraldsdottir; Mitesh J Borad
Journal:  F1000Res       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.